Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4, Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4, Provides Business Update

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Revenue of $3.14M

March 9, 2022 4:05 PM EST

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported Q4 revenue of $3.14 million, versus $0 reported last year.

Expect at least $8.0 million in LIVMARLI net product sales in first quarter 2022.

For earnings history and earnings-related data on Mirum Pharmaceuticals, Inc. (MIRM) click here.

... More